Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells

Background/Aim. Newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL) tretaed with immunochemotherapy have durable remission and improved overall survival. It is important to identify high risk patients who may benefit from even more effective therapies. Methods. In a group of 50 newly...

Full description

Bibliographic Details
Main Authors: Peruničić-Jovanović Maja, Jaković Ljubomir, Bogdanović Andrija, Marković Olivera, Čemerikić-Martinović Vesna, Mihaljević Biljana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2009-01-01
Series:Vojnosanitetski Pregled
Subjects:
lymphoma, B-cell
genes, bcl-2
Ki-67 antigen
prognosis
antineoplastic combined chemotherapy protocols
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500909738P.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500909738P.pdf

Similar Items